These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 15328386)

  • 1. Effects of endothelin-1 and endothelin-1-receptor blockade on renal function in humans.
    Vuurmans JL; Boer P; Koomans HA
    Nephrol Dial Transplant; 2004 Nov; 19(11):2742-6. PubMed ID: 15328386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of endothelin-1 and endothelin-1 receptor blockade on cardiac output, aortic pressure, and pulse wave velocity in humans.
    Vuurmans TJ; Boer P; Koomans HA
    Hypertension; 2003 Jun; 41(6):1253-8. PubMed ID: 12743011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haemodynamic and renal effects of endothelin receptor antagonism in patients with chronic kidney disease.
    Dhaun N; Ferro CJ; Davenport AP; Haynes WG; Goddard J; Webb DJ
    Nephrol Dial Transplant; 2007 Nov; 22(11):3228-34. PubMed ID: 17556408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelin receptor antagonist reverses decreased NO system in the kidney in vivo during exercise.
    Maeda S; Miyauchi T; Iemitsu M; Tanabe T; Goto K; Yamaguchi I; Matsuda M
    Am J Physiol Endocrinol Metab; 2004 Apr; 286(4):E609-14. PubMed ID: 14665447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of endothelin receptors ET(A) and ET(B) blockade on renal haemodynamics in normal rats and in rats with experimental congestive heart failure.
    Abassi Z; Francis B; Wessale J; Ovcharenko E; Winaver J; Hoffman A
    Clin Sci (Lond); 2002 Aug; 103 Suppl 48():245S-248S. PubMed ID: 12193096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ro 61-1790, a new hydrosoluble endothelin antagonist: general pharmacology and effects on experimental cerebral vasospasm.
    Roux S; Breu V; Giller T; Neidhart W; Ramuz H; Coassolo P; Clozel JP; Clozel M
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1110-8. PubMed ID: 9399983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of tezosentan, a dual endothelin receptor antagonist, on the cardiovascular and renal systems of neonatal piglets.
    Chin A; Radhakrishnan J; Fornell L; John E
    J Pediatr Surg; 2001 Dec; 36(12):1824-8. PubMed ID: 11733915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of isradipine on renal haemodynamics and systemic blood pressure changes induced by intravenous infusion of endothelin in healthy humans.
    Sørensen SS; Jensen JD; Madsen JK; Pedersen EB
    Nephrol Dial Transplant; 1995; 10(8):1324-31. PubMed ID: 8538922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-dependent acute and sustained renal effects of the endothelin receptor antagonist avosentan in healthy subjects.
    Smolander J; Vogt B; Maillard M; Zweiacker C; Littke T; Hengelage T; Burnier M
    Clin Pharmacol Ther; 2009 Jun; 85(6):628-34. PubMed ID: 19279566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelin-1 in chronic renal failure and hypertension.
    Larivière R; Lebel M
    Can J Physiol Pharmacol; 2003 Jun; 81(6):607-21. PubMed ID: 12839272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Administration of selective endothelin receptor type A antagonist Ro 61-1790 does not improve outcome in focal cerebral ischemia in cat.
    Bhardwaj A; Wu Y; Hurn PD; Kirsch JR; Traystman RJ
    J Cereb Blood Flow Metab; 2000 Mar; 20(3):499-504. PubMed ID: 10724114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The endothelin receptor antagonist tezosentan improves renal microcirculation in a porcine model of endotoxemic shock.
    Fenhammar J; Andersson A; Frithiof R; Forestier J; Weitzberg E; Sollevi A; Hjelmqvist H
    Acta Anaesthesiol Scand; 2008 Nov; 52(10):1385-93. PubMed ID: 19025532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic administration of phosphodiesterase type 5 inhibitor suppresses renal production of endothelin-1 in dogs with congestive heart failure.
    Yamamoto T; Wada A; Ohnishi M; Tsutamoto T; Fujii M; Matsumoto T; Takayama T; Wang X; Kurokawa K; Kinoshita M
    Clin Sci (Lond); 2002 Aug; 103 Suppl 48():258S-262S. PubMed ID: 12193099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low NaCl intake elevates renal medullary endothelin-1 and endothelin A (ETA) receptor mRNA but not the sensitivity of renal Na+ excretion to ETA receptor blockade in rats.
    Klinger F; Grimm R; Steinbach A; Tanneberger M; Kunert-Keil C; Rettig R; Grisk O
    Acta Physiol (Oxf); 2008 Mar; 192(3):429-42. PubMed ID: 17892519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and pharmacodynamics of SB 209670, an endothelin receptor antagonist: effects on the regulation of renal vascular tone.
    Freed MI; Wilson DE; Thompson KA; Harris RZ; Ilson BE; Jorkasky DK
    Clin Pharmacol Ther; 1999 May; 65(5):473-82. PubMed ID: 10340912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathophysiological roles of endogenous endothelin-1 in dogs with chronic heart failure produced by rapid right ventricular pacing.
    Tadano K; Suzuki J; Hanada K; Nakao M; Nakao R; Uehara S; Ohta H; Miyauchi T; Nishikibe M
    J Pharmacol Exp Ther; 2001 Aug; 298(2):729-36. PubMed ID: 11454937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effects of endothelin receptor antagonists in dogs with aortic cross-clamping.
    Roux S; Qiu C; Sprecher U; Osterwalder R; Clozel JP
    J Cardiovasc Pharmacol; 1999 Aug; 34(2):199-205. PubMed ID: 10445670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of endothelin and endothelin receptor antagonists in renal disease.
    Neuhofer W; Pittrow D
    Eur J Clin Invest; 2006 Sep; 36 Suppl 3():78-88. PubMed ID: 16919017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of KW-3902, an adenosine A1 receptor antagonist, on renal function and renal plasma flow in ambulatory patients with heart failure and renal impairment.
    Dittrich HC; Gupta DK; Hack TC; Dowling T; Callahan J; Thomson S
    J Card Fail; 2007 Oct; 13(8):609-17. PubMed ID: 17923351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The distinct alterations produced in cardiovascular functions by prednisolone and nitro-prednisolone (NCX-1015) in the rat highlight a causal role for endothelin-1.
    Di Filippo C; Rossi F; Ongini E; Del Soldato P; Perretti M; D'Amico M
    J Pharmacol Exp Ther; 2004 Sep; 310(3):1133-41. PubMed ID: 15113846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.